| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |